ArticleFrontiers in oncology2021

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.